- OncoTree
- PTH
Loading cancer entity…
Loading cancer entity…
Clinical trials
15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07843901 | Lenvatinib in Patients With Advanced Parathyroid Carcinoma(ALPS) | not yet recruiting | Phase 2 | 18 | Yonsei UniversityOTHER | 0 | Sep 28, 2026 | clinicaltrials |
| NCT04969926 | Natural History Study of Parathyroid Disorders | recruiting | — | 3,000 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 17, 2026 |
| clinicaltrials |
| NCT07444723 | Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors | recruiting | Phase 2 / Phase 3 | 193 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06638931 | Agnostic Therapy in Rare Solid Tumors(ANTARES) | recruiting | Phase 2 | 28 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT07475780 | Radiofrequency Ablation For Recurrent Parathyroid Carcinoma | recruiting | N/A | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT06852144 | PET-TC in Thyroid Evaluation(PEPATI-MN-2024) | enrolling by invitation | — | 418 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 28, 2025 | clinicaltrials |
Data updated yesterdaySource updated Sep 28, 2026source: clinicaltrials